Viewing Study NCT03639935

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:13 PM
Ignite Modification Date: 2026-02-25 @ 9:39 PM
Study NCT ID: NCT03639935
Status: COMPLETED
Last Update Posted: 2025-06-03
First Post: 2018-08-17
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Rucaparib in Combination With Nivolumab in Patients With Advanced or Metastatic Biliary Tract Cancer Following Platinum Therapy
Sponsor: University of Michigan Rogel Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Biliary Tract Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metastatic View
None Platinum View
None Rucaparib View
None Nivolumab View
None PARP Inhibitor View
None Anti-PD-1 Antibody View